-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Jc4vywJFqQNi+xSlcDxM4+s17ckBKDJUW69U4QyJDuCw0QO4EAzBvtcs/oEaIGuc duZyRVQ3hAHBYEEq+qaflw== 0000315066-96-000867.txt : 19960216 0000315066-96-000867.hdr.sgml : 19960216 ACCESSION NUMBER: 0000315066-96-000867 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960214 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TELOR OPHTHALMIC PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000887757 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133464527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43061 FILM NUMBER: 96518973 BUSINESS ADDRESS: STREET 1: 790 TURNPIKE STREET CITY: N ANDOVER STATE: MA ZIP: 01845 BUSINESS PHONE: 5086578400 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FMR CORP CENTRAL INDEX KEY: 0000315066 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 161144965 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 82 DEVONSHIRE ST CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6175706339 MAIL ADDRESS: STREET 1: 82 DEVONSHIRE STREET CITY: BOSTON STATE: MA ZIP: 02109 SC 13G/A 1 SCHEDULE 13G - 2-14-96 - TELOR OPHTHALMIC PHARMACEUTICALS INCORPORATED SCHEDULE 13G Amendment No. 2 Telor Ophthalmic Pharmaceuticals Incorporated Common Stock Cusip # 87969G100 Filing Fee: No Cusip # 87969G100 Item 1: Reporting Person - FMR Corp. - (Tax ID: 04-2507163) Item 4: Commonwealth of Massachusetts Item 5: None Item 6: None Item 7: None Item 8: None Item 9: None Item 11: 0.00% Item 12: HC Cusip # 87969G100 Item 1: Reporting Person - Edward C. Johnson 3d - (Tax ID: ###-##-####) Item 4: United States of America Item 5: None Item 6: None Item 7: None Item 8: None Item 9: None Item 11: 0.00% Item 12: IN Cusip # 87969G100 Item 1: Reporting Person - Abigail P. Johnson - (Tax ID: ###-##-####) Item 4: United States of America Item 5: None Item 6: None Item 7: None Item 8: None Item 9: None Item 11: 0.00% Item 12: IN SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b) Item 1(a). Name of Issuer: Telor Ophthalmic Pharmaceuticals Incorporated Item 1(b). Name of Issuer's Principal Executive Offices: 265 Ballardvale St., Wilmington, MA 01887 Item 2(a). Name of Person Filing: FMR Corp. Item 2(b). Address or Principal Business Office or, if None, Residence: 82 Devonshire Street, Boston, Massachusetts 02109 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 87969G100 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) and the person filing, FMR Corp., is a parent holding company in accordance with Section 240.13d-1(b)(ii)(G). (Note: See Item 7). Item 4. Ownership (a) Amount Beneficially Owned: None (b) Percent of Class: 0.00% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: None (ii) shared power to vote or to direct the vote: None (iii) sole power to dispose or to direct the disposition of: None (iv) shared power to dispose or to direct the disposition of: None Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof, the reporting person has ceased to be the beneficial owner of any of the class of securities, check the following (X). Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. Inasmuch as the reporting persons are no longer the beneficial owners of any of the number of shares outstanding, the reporting persons have no further reporting obligation under section 13(d) of the Securities and Exchange Commission thereunder, and the reporting persons have no obligation to amend this Statement if any material change occurs in the facts set forth herein. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Schedule 13G in connection with FMR Corp.'s beneficial ownership of the common stock of Telor Ophthalmic Pharmaceuticals Incorporated at December 31, 1995 is true, complete and correct. February 14, 1996 Date /s/Arthur S. Loring Signature Arthur S. Loring, Vice President Name/Title -----END PRIVACY-ENHANCED MESSAGE-----